Canaloplasty heralds a new era in glaucoma surgery

Article

Dr Matthias Grieshaber advises surgeons to implement this technique into their armamentarium.

Related Videos
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Kasperi Kankare at the iCare booth at ESCRS
Disrupting the glaucoma treatment paradigm with novel femtosecond laser from ViaLase
2-year data in contralateral eye evaluation gives edge to iStent inject over Hydrus stent
Should endocyclophotocoagulation be considered part of MIGS? Mr Ratnarajan delves in
Investigating the effects of canaloplasty on corneal epithelium
Related Content
A hand balances an energy sphere. Image credit: ©Who is Danny – stock.adobe.com

Machine learning: A view from new angles

November 2nd 2023
Article

More testing is needed to ensure accuracy across different groups

A doctor sits at a desk, writing on a clipboard and typing on a computer. Image credit: ©ING Studio 1985 – stock.adobe.com

PAUL implant: Good IOP lowering, fewer complications compared with Baerveldt device

October 3rd 2023
Article

Results showed that the PAUL Glaucoma Implant is an effective glaucoma drainage device that provides effective IOP lowering, similar to that achieved with the Baerveldt Glaucoma Implant, but with lower rates of complications

Gonioscopy-assisted transluminal trabeculotomy (GATT) offers relief for patients undergoing corneal transplant

Gonioscopy-assisted transluminal trabeculotomy (GATT) offers relief for patients undergoing corneal transplant

October 2nd 2023
Article

The approach to lowering intraocular pressure reduces medication burden without risking graft rejection

A group of doctors and scientists walk through a laboratory. Image credit: ©Oostendorp/peopleimages.com – stock.adobe.com

Study: MERCURY-3 trial results support efficacy of Roclanda

September 13th 2023
Article

MERCURY-3 trial data show latanoprost/netarsudil fixed-dose combination (Roclanda) demonstrated comparable IOP lowering efficacy to bimatoprost/timolol combination, in patients with primary open-angle glaucoma or ocular hypertension.

An imaging device shows intraocular pressure. Image Credit: ©sompong_tom – stock.adobe.com

Ciliatech presents clinical trial results from SAFARI III glaucoma study

September 7th 2023
Article

The company announced new data on outcomes for both open and narrow angle glaucoma patients.

A doctor in a white coat shakes hands with someone off-screen. Image credit: ©bnenin – stock.adobe.com

BVI acquires Medical Mix, expanding its presence in Europe

September 6th 2023
Article

According to the company, the deal expands its European footprint into Spain and Portugal.

© 2023 MJH Life Sciences

All rights reserved.